News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
CSL Limited Plans A$900 (US$815) Million Share Buyback After Net Profit Slips
August 18, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Wall Street Journal -- SYDNEY—CSL Ltd. said its full-year net profit fell 8% and the company unveiled a 900 million Australian dollar (US$815 million) share buyback.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Asia
Australia
MORE ON THIS TOPIC
Manufacturing
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans
May 6, 2025
·
2 min read
·
Tristan Manalac
Earnings
Vertex Shrugs Off Q1 Miss With ‘Strong’ Journavx Launch, Encouraging Pipeline Position
May 6, 2025
·
2 min read
·
Tristan Manalac
Layoffs
BMS Axes 516 More Employees in New Jersey
May 5, 2025
·
2 min read
·
Angela Gabriel
Earnings
BioNTech’s Ambitious PD-L1/VEGF Plans Currently Rely on Chinese Manufacturing
May 5, 2025
·
3 min read
·
Tristan Manalac
